Biomarkers of endothelial dysfunction in cardiovascular diseases

Endothelial Progenitor Cell Dysfunction in Polycystic Ovary Syndrome: Implications for The Genesis of Cardiovascular Diseases

Tetrahydrobiopterin and Endothelial Dysfunction in Cardiovascular Diseases

Endothelial vasodilator dysfunction is a characteristic feature of patients at risk for coronary atherosclerosis. We have reported that insulin resistance may be a pathogenic factor for endothelial dysfunction through impaired endothelial nitric oxide synthase (eNOS) activity and increased oxidative breakdown of nitric oxide (NO) due to an enhanced formation of superoxide anion, which are cause...

Biomarkers of endothelial activation/dysfunction in infectious diseases

Endothelial dysfunction contributes to the pathogenesis of a variety of potentially serious infectious diseases and syndromes, including sepsis and septic shock, hemolytic-uremic syndrome, severe malaria, and dengue hemorrhagic fever. Because endothelial activation often precedes overt endothelial dysfunction, biomarkers of the activated endothelium in serum and/or plasma may be detectable befo...

endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseases

0

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

The endothelium plays a vital role in maintaining circulatory homeostasis by the release of relaxing and contracting factors. Any change in this balance may result in a process known as endothelial dysfunction that leads to impaired control of vascular tone and contributes to the pathogenesis of some cardiovascular and endocrine/metabolic diseases. Reduced endothelium-derived nitric oxide (NO) ...